Iris Acquisition Corp | SPAC Research

Iris Acquisition Corp

Status: Live Deal

U=S+W/4 W=S@11.5

IPO Proceeds, $M	$276.00M
IPO Date	Mar 5, 2021
CEO	Sumit Mehta
Left Lead	Cantor Fitzgerald
IPO Cash in Trust	100.0%
SPAC Tenor	24 + 6 + 6 + 6 + 3 + 3
IPO Sector	General ▶
IPO Geography	Global
Target Company	Liminatus Pharma
Deal Announced	Nov 30, 2022
Deal Size, $M	$175.00M
Deal Sector	Healthcare
Deal Geography	US/Canada
SEC Filings	www.sec.gov
Approval Vote	Mar 4, 2025
Amendment Vote	Dec 20, 2024

IRAA IRAAU IRAAW

Price	$11.00
Last closing price	$11.05
H/L, today	$5.01 / $5.01
H/L, 52-week	$9.70 / $11.22
Volume, today	100
Volume, 3-month avg.	N/A

Price	$2.01
Last closing price	$10.70
High/low price, today	$2.01 / $2.01
High/low price, 52-week	$9.53 / $11.40
Volume, today	100
Volume, 3-month avg.	N/A

Price	$0.06
Last closing price	$0.07
High/low price, today	$0.03 / $0.03
High/low price, 52-week	$0.02 / $0.15
Volume, today	1,015
Volume, 3-month avg.	N/A

Price
Volume, today
Volume, 3-month avg.	N/A

Sign up for Free Trial

No credit card required

Sign in to view structure, cap table, and calendar of events.